HEALTH: Requests the Louisiana Department of Health to study prevention and reduction of diabetes-related amputations
House Resolution 267 is a nonbinding legislative request directing the Louisiana Department of Health, working with the Louisiana Center for Health Innovation at the University of Louisiana at Lafayette and other stakeholders, to study how to prevent and reduce amputations caused by diabetes and related complications. The resolution frames diabetes-related amputations as a major public health problem in Louisiana, emphasizing that many of these amputations are preventable through earlier detection, coordinated care, patient education, and better access to treatment.
The study is required to examine the prevalence and state costs of diabetes-related amputations, identify evidence-based prevention practices, and evaluate ways to expand access to limb-saving services such as multidisciplinary care, wound care, podiatry, and patient education. It also asks for review of public-private partnerships, advanced therapies, in-home services, and policy options such as insurance coverage for treatments for diabetic foot ulcers. The department must convene or appoint a workgroup of medical experts, public health representatives, and affected individuals, and then report findings and recommendations to the House and Senate Health and Welfare Committees by December 1, 2026, with the report made public.
Because this is a resolution rather than a statute, HR267 does not directly change Louisiana law or create enforceable rights or duties for patients, providers, or insurers. Its practical effect is to initiate a state-sponsored policy study and reporting process that could inform future legislation, administrative action, or funding decisions related to diabetes care, wound care, vascular services, and amputation prevention. It also directs collaboration between LDH and a university research center and calls for a public report, which may influence how state health policy is developed around diabetic complications.
The overall sentiment around the resolution is supportive and public-health oriented, with the bill presenting diabetes-related amputations as a preventable and costly problem that warrants coordinated study. The text reflects a consensus-style approach focused on research, stakeholder input, and evidence-based recommendations rather than immediate regulatory change. No committee transcript or vote record is provided, so there is no recorded opposition or debate in the available materials.
No formal contention is shown in the available record, but the resolution’s scope suggests potential policy debates around cost, insurance coverage, and the inclusion of advanced or emerging therapies such as skin substitutes, topical oxygen therapy, autologous 3D bio-printing, and in-home services. Stakeholders who may differ include insurers, providers, and policymakers over which treatments should be covered, how broadly access should be expanded, and what evidence threshold should be used for recommendations. The bill itself anticipates these issues by asking the study to evaluate access, incentives for quality care, and public-private partnerships.